Zymergi LogoCart

483 Document: UCB Pharma S.A., Feb 4, 2022

FDANews 483 UCB Pharma S.A. Feb 4 2022 top
Wayne E. Seifert FDA Investigator Roger F. Zabinski FDA Investigator

On Feb 04, 2022, the FDA inspected UCB Pharma S.A.'s Braine-l'alleud site. Explore the inspectional observations.